Method for in vitro detection of content of readily exchangeable magnesium ions in bone mineral
By reacting alendronic acid with bone minerals to release readily exchangeable magnesium ions, the accuracy of magnesium ion detection in bone minerals is solved, enabling efficient detection of bone health and artificial bone repair materials.
Patent Information
- Application Number
- PCT/CN2025/093787
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-09
- Publication Date
- 2026-11-12
AI Technical Summary
Existing technologies cannot accurately detect the content of exchangeable magnesium ions in bone minerals, making it impossible to effectively assess bone magnesium status and affecting the assessment of bone health and the chemical testing of artificial bone repair materials.
The interaction between alendronic acid and bone minerals in aqueous solution releases easily exchangeable magnesium ions into the solution. The mass percentage of easily exchangeable magnesium ions is calculated by measuring the concentration of magnesium ions in the solution.
This study provides a simple and accurate method for the efficient detection of exchangeable magnesium ions in bone minerals. It is applicable to the detection of these ions in clinical settings and artificial bone repair materials, and promotes the accurate evaluation of bone magnesium status and the study of related biochemical indicators.
Smart Images

Figure PCTCN2025093787-FTAPPB-I100001
Abstract
Description
An in vitro method for detecting the content of exchangeable magnesium ions in bone minerals Technical Field
[0001] This invention relates to the fields of bone composition detection technology, artificial bone repair materials, and chemical evaluation of other bone organs in the fields of biology and medicine; specifically, it relates to an in vitro detection method for the content of easily exchangeable magnesium ions in bone minerals. Background Technology
[0002] Magnesium is an essential metallic element for the human body, playing a vital role in ATP synthesis, DNA and RNA structural stability, enzymatic reactions, normal heart function, and blood pressure stability. Therefore, it is important to accurately assess magnesium status.
[0003] By mass, approximately 60% of the total magnesium in the human body (usually 25±3g) is stored in bones, of which bone magnesium accounts for about 0.5% of bone minerals. The remaining approximately 40% of the total magnesium in the human body exists in soft tissues and extracellular fluid, of which magnesium in extracellular fluid accounts for only 1% of the total magnesium in the human body, of which about 5%–10% of exchangeable magnesium is bound to anions (such as phosphate, citrate, and carbonate ions) [ARMorrison. Magnesium homeostasis: Lessons from human genetics. Clin. J. Am. Soc. Nephrol. 18, 969-978 (2023)]. Serum magnesium ions (Mg 2+ The homeostasis of Mg depends on the synergistic effects of the gut, bones, and kidneys (Figure 1a); 2+ In cases of temporary deficiency, it mainly relies on the release of easily exchangeable magnesium from bones. 2+ (Readily exchangeable magnesium, REM) to maintain a stable serum magnesium concentration (0.7-1.25 mmol / L) [J. Vormann. Magnesium: nutrition and homoeostasis. AIMS Public Health 3, 329-340 (2016)].
[0004] Magnesium ions have a variety of physiological functions (Figure 1b). They are cofactors for more than 300 enzymes in the body and participate in over 600 enzymatic reactions [FHNielsen. Dietary magnesium and chronic disease. Adv. Chronic Kidney D. 25, 230-235 (2018)], playing a crucial role in ATP synthesis. Magnesium can stabilize the structure of nucleic acids (DNA and RNA) [K. Nam, ARATHodika, S. Tischlik, C. Phoeurk, TMNagy, L. Schierholz, J.]. P. Rogne, M. Drescher, A. E. Sauer-Eriksson, M. Wolf-Watz. Magnesium-induced structural reorganization in the active site of adenylate kinase. Sci. Adv. 10, eado 5504 (2024)] plays a crucial role in muscle contraction and neural signal regulation [R. Yamagami, J. B. Bingaman, E. A. Frankel, P. C. P. Vilacqua. Cellular conditions of weakly chelated magnesium ions strongly promote RNAstability and catalysis. Nat. Commun. 9, 2149 (2018)], supports calcium metabolism, and is essential for maintaining bone mineral density and preventing osteoporosis [M. Farsinejad-Marj, P. Saneei, A. Esmaillzadeh. Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis. Osteoporos Int.27, 1389–1399 (2016)).Furthermore, magnesium is involved in signaling pathways crucial to various cellular processes, playing a vital role in insulin secretion and signal transduction [SRde Sousa Melo, LRdos Santos, T. da Cunha Soares, B. Cardoso, T. Dias, J. Morais, M. Sousa, T. Sousa, N. Silva, L. Silva, K. Cruz, D. Marreiro. Participation of magnesium in the secretion and signaling pathways of insulin: an updated review. Biol. Trace Elem. Res. 200, 3545-3553 (2022)]. Magnesium-deficient mice also exhibit enhanced anxiety-related behaviors [SBSartori, N. Whittle, A. Hetzenauer, N. Singewald. Magnesium deficiency induces anxiety and HPAaxis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology]. [62,304-312(2012)], plays an important role in maintaining a healthy heart rhythm and is involved in the regulation of blood pressure [M. Houston. The role of magnesium in hypertension and cardiovascular disease. J. Clin. Hypertens (Greenwich) 13,843-847(2011)], and alleviates oxidative stress in the rat retina by increasing the activity of antioxidant enzymes (SOD, CAT and GPx) [C. Orhan, B. Er, PBD Deeh, AABilgic, SPOjalvo, JR Komorowski, K. Sahin. Different sources of dietary magnesium supplementation reduces oxidative stress by regulation Nrf2 and NF-κB signaling pathways in high-fat diet rats. Biol. Trace Elem. Res. 199, 4162–4170(2021)].
[0005] When dietary magnesium intake is insufficient, readily exchangeable magnesium stored in bones is released to maintain essential magnesium levels in soft tissues and extracellular fluid. 2+ Horizontal. Utilization 25 Mg and 26 Studies on magnesium metabolism kinetics using Mg isotopes have shown that approximately 24% of the magnesium in the body of healthy men is rapidly exchanged, indicating that the readily exchangeable magnesium content in bone represents a magnesium ion pool that can form a close buffer with the extracellular fluid magnesium concentration [M. Sabatier, F. Pont, M. J. Arnaud, J. R. Turnlund. A comparative model of magnesium metabolism in healthy men based on two stable isotope tracers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R656-663 (2003)]. Research has shown that this magnesium buffering capacity declines with age throughout a person's life, eventually resulting in the loss of nearly half of the readily exchangeable magnesium in bones. This magnesium loss includes a decrease in readily exchangeable magnesium content and the loss of magnesium from external sources. 2+ Two possible scenarios for difficulty in accessing the magnesium ion pool [AIMS Public Health 3, 329-340 (2016)].
[0006] In clinical practice, the primary medical method for directly detecting magnesium ion content in bone minerals is bone biopsy. Indirect methods for reflecting bone health and assessing bone magnesium status include dual-energy X-ray absorptiometry (DXA), ultrasound bone mineral density testing, imaging techniques (such as MRI), and biochemical indicators that can reflect bone magnesium status, such as serum magnesium levels or 24-hour urinary magnesium excretion. However, studies have not found that changes in bone mineral density can indicate bone magnesium status [RKRude, HEGruber. Magnesium deficiency and osteoporosis: animal and human observations. J. Nutr. Biochem. 15, 710-716 (2004)], highlighting the need for identification and quantification of magnesium ions in bone. 2+ Horizontal imaging techniques (such as MRI, fluorescent probes) are also still in their early stages [ACSeifert, ACWright, SLWehrli, HHOng, C.Li, FWWehrli]. 31P NMR relaxation of cortical bone mineral at multiple magnetic field strengths and levels of demineralization. NMR Biomed. 6, 1158-1166 (2013); M. Liu, 2+ ): from design to application.RSC Adv.8,12573-12587(2018); B.Pinto-Pacheco, Q.Lin, CWYan, S.de Melo Silva, D.Buccella. Lanthanide-based luminescent probes for biological magnesium: accessing polyphosphate-bound Mg 2+ .Chem.Commun.59,3586-3589(2023)]. 25 Mg and 26 Although stable Mg isotopes have been used to determine the REM content of bone magnesium [Am.J.Physiol.Regul.Integr.Comp.Physiol.285,R656-663(2003)], their high abundance makes it difficult to indicate the magnesium state using only a small amount of isotopes. 28 The half-life of Mg does not match that of bone magnesium, resulting in a large testing error and therefore it is not commonly used in research [Brit. J. Nutr. 99 (S3), S24-S36 (2008)]. Summary of the Invention
[0007] To overcome the above problems, this invention provides a method for detecting the content of easily exchangeable magnesium ions in bone minerals based on the principle of interaction between alendronic acid and bone minerals. By allowing an appropriate amount of alendronic acid to interact with bone minerals in an aqueous solution, the easily exchangeable magnesium ions in the bone minerals are completely released into the aqueous solution. The concentration of magnesium ions in the aqueous solution is measured, and then the mass of the easily exchangeable magnesium ions and its percentage of the total mass of magnesium ions contained in the bone minerals are calculated, i.e., the percentage content of easily exchangeable magnesium ions in the bone minerals. This method is very suitable for clinical detection of the content of easily exchangeable magnesium ions in bone minerals, as well as for the chemical detection of the content of easily exchangeable magnesium ions in artificial bone repair materials and other bone organoids.
[0008] Therefore, the present invention provides an in vitro detection method for the content of readily exchangeable magnesium ions in bone minerals, comprising: reacting an appropriate amount of bone minerals with alendronic acid in water, then measuring the concentration of magnesium ions in the aqueous solution, calculating the total mass M1 of magnesium ions in the aqueous solution, and then calculating the percentage content of readily exchangeable magnesium ions in the bone minerals by formula (M1 / M0)×100%, wherein M0 represents the total mass of magnesium ions contained in the bone minerals.
[0009] In this article, the percentage of exchangeable magnesium ions in bone minerals refers to the percentage of the mass of exchangeable magnesium ions in bone minerals relative to the total mass of magnesium ions.
[0010] In some embodiments, the present invention provides an in vitro detection method for the content of readily exchangeable magnesium ions in bone minerals, comprising: reacting an appropriate amount of bone minerals with alendronic acid in water; after the reaction is complete, separating the reaction mixture into solid and liquid components; adjusting the pH of the resulting filtrate to acidic; measuring the concentration of magnesium ions in the solution; calculating the total mass M1 of magnesium ions in the aqueous solution; and then calculating the percentage content of readily exchangeable magnesium ions in the bone minerals using the formula (M1 / M0)×100%, where M0 represents the total mass of magnesium ions contained in the bone minerals.
[0011] In some embodiments, in the in vitro detection method for the content of readily exchangeable magnesium ions in bone minerals provided by the present invention, the weight ratio of alendronic acid to the bone minerals is (4.0-15.0):100; preferably, the weight ratio of alendronic acid to the bone minerals is (4.0-10.0):100; more preferably, the weight ratio of alendronic acid to the bone minerals is (5.0-8.0):100. In some embodiments, in the in vitro detection method for the content of readily exchangeable magnesium ions in bone minerals provided by the present invention, the weight ratio of alendronic acid to the bone minerals is 4.0:100, 5.0:100, 6.0:100, 7.0:100, 8.0:100, 9.0:100, 10.0:100, 11.0:100, 12.0:100, 13.0:100, 14.0:100, or 15.0:100.
[0012] In some embodiments, in the in vitro detection method for the content of easily exchangeable magnesium ions in bone provided by the present invention, the weight ratio of the bone minerals to the water is (1-2):100.
[0013] In some embodiments, in the in vitro detection method for the content of easily exchangeable magnesium ions in bone provided by the present invention, the temperature at which the bone minerals react with alendronic acid in water is 20°C to 60°C; preferably 20°C to 50°C; more preferably 20°C to 40°C; and most preferably 20°C to 36°C. In some embodiments, the temperature at which the bone minerals react with alendronic acid in water is 20°C, 21°C, 22°C, 23°C, 24°C, 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, 40°C, 41°C, 42°C, 43°C, 44°C, 45°C, 46°C, 47°C, 48°C, 49°C, 50°C, 51°C, 52°C, 53°C, 54°C, 55°C, 56°C, 57°C, 58°C, 59°C, or 60°C.
[0014] In some embodiments, in the in vitro detection method for the content of easily exchangeable magnesium ions in bone provided by the present invention, the reaction time of the bone minerals and alendronic acid in water is 48-200 h; preferably 72-150 h; more preferably 96-120 h.
[0015] In some embodiments, in the in vitro detection method for the content of easily exchangeable magnesium ions in bone provided by the present invention, the contact reaction between the bone minerals and alendronic acid in water is carried out under stirring conditions, wherein the stirring rate is 10-1000 rpm, preferably 20-800 rpm, more preferably 20-600 rpm, more preferably 20-500 rpm, more preferably 20-300 rpm, and more preferably 60-300 rpm.
[0016] In some embodiments, the in vitro detection method for the content of easily exchangeable magnesium ions in bone minerals provided by the present invention uses powdered bone minerals.
[0017] In some embodiments, in the in vitro detection method for the content of readily exchangeable magnesium ions in bone minerals provided by the present invention, the concentration of magnesium ions in the solution is determined by inductively coupled plasma atomic emission spectrometry or inductively coupled plasma mass spectrometry.
[0018] In some embodiments, in the in vitro detection method for the content of easily exchangeable magnesium ions in bone minerals provided by the present invention, the pH value of the obtained filtrate is adjusted to 1.0-5.0; preferably, the pH value of the obtained filtrate is adjusted to 2.0-4.0; more preferably, the pH value of the obtained filtrate is adjusted to 2.5-3.5; even more preferably, the pH value of the obtained filtrate is adjusted to 2.5-3.0.
[0019] In some embodiments, the in vitro detection method for the content of readily exchangeable magnesium ions in bone minerals provided by the present invention further includes the preparation of the bone minerals:
[0020] Take an appropriate amount of bone sample and heat it with water to react. After cooling, take out the bone sample and grind it into powder. Soak the powdered sample in hydrogen peroxide and then separate the solid and liquid. Put the obtained solid sample into an ethanol-water solution, heat and stir, then separate the solid and liquid. Dry the obtained solid sample to obtain powdered bone minerals.
[0021] In some embodiments, the in vitro detection method for the content of readily exchangeable magnesium ions in bone minerals provided by the present invention further includes the preparation of the bone minerals:
[0022] Take an appropriate amount of bone sample and water and heat it in a hydrothermal reactor made of polytetrafluoroethylene. After cooling, take out the bone sample and grind it into powder. Soak the powdered sample in hydrogen peroxide and then separate the solid and liquid. Put the obtained solid sample into an ethanol-water solution, heat and stir, then separate the solid and liquid. Dry the obtained solid sample to obtain powdered bone minerals.
[0023] In some embodiments, in the in vitro detection method for the content of easily exchangeable magnesium ions in bone minerals provided by the present invention, the total mass of magnesium ions contained in the bone minerals is determined by acid digestion of the bone minerals.
[0024] Weigh a certain mass of bone minerals, add an appropriate amount of concentrated hydrochloric acid or concentrated nitric acid as a solvent, sonicate to completely dissolve the bone minerals, adjust the pH of the resulting solution to 2.0-3.5, and dilute to volume with water; determine the concentration of magnesium ions in the resulting solution, and calculate the total mass of magnesium ions contained in the bone minerals.
[0025] In some embodiments, the in vitro detection method for the content of easily exchangeable magnesium ions in bone provided by the present invention includes:
[0026] Take an appropriate amount of bone sample and heat it with water to react. After cooling, take out the bone sample and grind it into powder. Soak the powdered sample in hydrogen peroxide and then separate the solid and liquid. Put the obtained solid sample into an ethanol-water solution, heat and stir, then separate the solid and liquid. Dry the obtained solid sample to obtain powdered bone minerals.
[0027] A suitable amount of powdered bone minerals is reacted with alendronic acid in water, and then the concentration of magnesium ions in the aqueous solution is measured. The total mass of magnesium ions in the aqueous solution, M1, is then calculated. The percentage content of easily exchangeable magnesium ions in the bone minerals is calculated using the formula (M1 / M0)×100%, where M0 represents the total mass of magnesium ions contained in the bone minerals.
[0028] The total mass of magnesium ions contained in the bone minerals was determined by acid digestion of the bone minerals: a certain mass of bone minerals was weighed, an appropriate amount of concentrated hydrochloric acid or concentrated nitric acid was added as a solvent, the bone minerals were completely dissolved by sonication, the pH of the resulting solution was adjusted to 2.0-3.5, and the volume was adjusted with water; the concentration of magnesium ions in the resulting solution was measured, and the total mass of magnesium ions contained in the bone minerals was calculated.
[0029] In some embodiments, the in vitro detection method for the content of easily exchangeable magnesium ions in bone minerals provided by the present invention includes:
[0030] Take an appropriate amount of bone sample and water and heat it in a hydrothermal reactor made of polytetrafluoroethylene. After cooling, take out the bone sample and grind it into powder. Soak the powdered sample in hydrogen peroxide and then separate the solid and liquid. Put the obtained solid sample into an ethanol-water solution, heat and stir, then separate the solid and liquid. Dry the obtained solid sample to obtain powdered bone minerals.
[0031] A suitable amount of powdered bone minerals is reacted with alendronic acid in water, and then the concentration of magnesium ions in the aqueous solution is measured. The total mass M1 of magnesium ions in the aqueous solution is then calculated. The percentage content of easily exchangeable magnesium ions in the bone minerals is calculated by the formula (M1 / M0)×100%, where M0 represents the total mass of magnesium ions contained in the bone minerals.
[0032] The total mass of magnesium ions contained in the bone minerals was determined by acid digestion of the bone minerals: a certain mass of bone minerals was weighed, an appropriate amount of concentrated hydrochloric acid or concentrated nitric acid was added as a solvent, the bone minerals were completely dissolved by sonication, the pH of the resulting solution was adjusted to 2.0-3.5, and the volume was adjusted with water; the concentration of magnesium ions in the resulting solution was measured, and the total mass of magnesium ions contained in the bone minerals was calculated.
[0033] In one specific embodiment, the in vitro detection method for the content of readily exchangeable magnesium ions in bone minerals provided by the present invention includes: reacting an appropriate amount of powdered bone minerals with alendronic acid in water for 96 hours; after the reaction is complete, performing solid-liquid separation on the reaction mixture (vacuum filtration or centrifugation); adjusting the pH of the obtained filtrate to approximately 2.8; and making up the volume with water; measuring the magnesium ion concentration in the obtained solution by ICP-OES; multiplying the concentration by the corresponding solution volume to calculate the total mass of magnesium ions in the solution M1 (mg); and calculating the content of readily exchangeable magnesium ions in the bone minerals based on the total mass of magnesium ions M0 (mg) contained in the bone minerals using the formula (M1 / M0)×100%.
[0034] In one specific embodiment, the in vitro detection method for the content of easily exchangeable magnesium ions in bone minerals provided by the present invention further includes the preparation of bone minerals: An appropriate amount of bone sample and water are added to a hydrothermal reactor made of polytetrafluoroethylene (PTFE) and reacted at 190°C for 3 hours. After cooling, the softened bone sample is removed and ground into powder in an agate mortar. The powdered sample is then immersed in 30% hydrogen peroxide at room temperature for 1-2 hours (ultrasound-assisted), followed by solid-liquid separation. The resulting solid sample is further placed in an ethanol-water solution (V / V = ~1 / 1), stirred at 85°C for 4 hours, and then separated again. The resulting solid sample is further dried using a rotary evaporator under reduced pressure at a drying temperature of 60-80°C, a vacuum degree below 50 mbar (0.095 kPa), a rotation speed of ~100 rpm, and a drying time of 1-2 hours. The resulting dried powder sample is the powdered bone mineral, which can be used directly or stored in a sealed container.
[0035] In one specific implementation, the in vitro detection method for the content of easily exchangeable magnesium ions in bone minerals provided by the present invention determines the total magnesium content of the bone minerals by acid digestion of the bone minerals. The method includes: weighing a certain mass of bone minerals into a quartz bottle, adding an appropriate amount of concentrated hydrochloric acid or concentrated nitric acid as a solvent to completely dissolve the bone sample (ultrasound-assisted); transferring the resulting sample solution to a 100mL volumetric flask; rinsing the quartz bottle with purified water (10mL × 3), transferring the rinsing solution to the volumetric flask; adding purified water slightly below the 100mL mark; adjusting the pH to approximately 2.8; and bringing the volume to 100mL. The magnesium ion content (C0, mg / L) in the resulting solution is measured by ICP-OES. Multiplying the measured magnesium content C0 by 100mL yields the total magnesium content of the bone minerals, M0 = 0.1C0 (mg).
[0036] In one specific implementation, the in vitro detection method for the content of easily exchangeable magnesium ions in bone minerals provided by the present invention includes:
[0037] An appropriate amount of bone sample and water were added to a hydrothermal reactor made of polytetrafluoroethylene (PTFE) and reacted at 190°C for 3 hours. After cooling, the softened bone sample was removed and ground into powder in an agate mortar. The powdered sample was then soaked in 30% hydrogen peroxide at room temperature for 1-2 hours (ultrasonic-assisted), followed by solid-liquid separation. The resulting solid sample was further placed in an ethanol-water solution (V / V = ~1 / 1) and stirred at 85°C for 4 hours, followed by solid-liquid separation. The resulting solid sample was then further dried using a rotary evaporator under reduced pressure at a temperature of 60-80°C, a vacuum of less than 50 mbar (0.095 kPa), a rotation speed of ~100 rpm, and a drying time of 1-2 hours. The resulting dried powder sample is the powdered bone mineral.
[0038] An appropriate amount of powdered bone minerals was reacted with alendronic acid in purified water for 96 hours. After the reaction was completed, the reaction mixture was separated into solid and liquid components (by filtration or centrifugation). The pH of the filtrate was adjusted to approximately 2.8, and the volume was brought up with purified water. The concentration of magnesium ions in the resulting solution was measured by ICP-OES. The concentration was then multiplied by the volume of the corresponding solution to calculate the total mass of magnesium ions in the solution, M1 (mg). Based on the total mass of magnesium ions contained in the bone minerals, M0 (mg), the content of easily exchangeable magnesium ions in the bone mineral sample was calculated using the formula (M1 / M0)×100%.
[0039] The total mass of magnesium ions contained in the bone minerals was determined using an acid digestion method. This method included: weighing a certain mass of bone minerals into a quartz bottle, adding an appropriate amount of concentrated hydrochloric acid or concentrated nitric acid as a solvent to completely dissolve the sample (with ultrasonic assistance), transferring the resulting solution to a 100mL volumetric flask, rinsing the quartz bottle with purified water (10mL x 3), transferring the rinsing solution to the volumetric flask, adding purified water slightly below the 100mL mark, adjusting the pH to approximately 2.8, and then bringing the volume to 100mL. The magnesium ion concentration (C0, mg / L) in the resulting solution was measured using ICP-OES. Multiplying the measured magnesium concentration C0 by 100mL yielded the total mass of magnesium ions in the bone mineral sample, M0 = 0.1C0 (mg).
[0040] In some embodiments, the bone samples described herein include natural bone, artificial bone repair materials, and other bone organoids. In some specific embodiments, the bone samples described herein are selected from natural bone.
[0041] In one embodiment, the present invention provides the use of alendronate for the in vitro detection of exchangeable magnesium ion content in bone minerals.
[0042] In one embodiment, the present invention provides the use of alendronic acid for the in vitro detection of the content of readily exchangeable magnesium ions in bone minerals, comprising reacting an appropriate amount of powdered bone minerals with alendronic acid in water, then measuring the concentration (C1) of magnesium ions in the aqueous solution, and then calculating the total mass M1 of magnesium ions in the aqueous solution by multiplying the concentration C1 by the corresponding solution volume, and calculating the percentage content of readily exchangeable magnesium ions in the bone minerals by the formula (M1 / M0)×100%, wherein M0 represents the total mass of magnesium ions contained in the bone minerals.
[0043] In one embodiment, the present invention provides the use of alendronate for the in vitro detection of exchangeable magnesium ion content in bone minerals, comprising:
[0044] Take an appropriate amount of bone sample and heat it with water to react. After cooling, take out the bone sample and grind it into powder. Soak the powdered sample in hydrogen peroxide (with ultrasound assistance) and then separate the solid and liquid. Put the obtained solid sample into an ethanol-water solution, heat and stir, then separate the solid and liquid, and dry the obtained solid sample to obtain powdered bone minerals.
[0045] An appropriate amount of powdered bone minerals is reacted with alendronic acid in water, and then the concentration of magnesium ions (C1) in the aqueous solution is measured. The total mass of magnesium ions in the aqueous solution, M1, is calculated by multiplying the concentration C1 by the corresponding solution volume. The percentage content of easily exchangeable magnesium ions in the bone minerals is calculated by the formula (M1 / M0)×100%, where M0 represents the total mass of magnesium ions contained in the bone minerals.
[0046] The total mass of magnesium ions contained in the bone minerals was determined by acid digestion of the bone minerals: a certain mass of bone minerals was weighed, an appropriate amount of concentrated hydrochloric acid or concentrated nitric acid was added as a solvent, and the bone minerals were completely dissolved with ultrasonic assistance. The pH of the resulting solution was adjusted to 2.0-3.5, and the volume was adjusted with water. The concentration of magnesium ions in the resulting solution was measured, and the total mass of magnesium ions contained in the bone minerals was calculated.
[0047] In one specific embodiment, the present invention provides the use of alendronate for the in vitro detection of exchangeable magnesium ion content in bone minerals, comprising:
[0048] An appropriate amount of bone sample and water were added to a hydrothermal reactor made of polytetrafluoroethylene (PTFE) and reacted at 190°C for 3 hours. After cooling, the softened bone sample was removed and ground into powder in an agate mortar. The powdered sample was then soaked in 30% hydrogen peroxide at room temperature for 1-2 hours (ultrasonic-assisted), followed by solid-liquid separation. The resulting solid sample was further placed in an ethanol-water solution (V / V = ~1 / 1) and stirred at 85°C for 4 hours, followed by solid-liquid separation. The resulting solid sample was then further dried using a rotary evaporator under reduced pressure at a temperature of 60-80°C, a vacuum of less than 50 mbar (0.095 kPa), a rotation speed of ~100 rpm, and a drying time of 1-2 hours. The resulting dried powder sample is the powdered bone mineral.
[0049] An appropriate amount of powdered bone minerals was reacted with alendronic acid in purified water for 96 hours. After the reaction was completed, the reaction mixture was separated into solid and liquid components (by filtration or centrifugation). The pH of the filtrate was adjusted to approximately 2.8 with hydrochloric acid (nitric acid), and then diluted to volume with purified water. The concentration of magnesium ions in the solution was measured by ICP-OES, and the total mass of magnesium ions in the solution, M1 (mg), was calculated. Based on the total mass of magnesium ions contained in the bone minerals, M0 (mg), the content of easily exchangeable magnesium ions in the bone minerals was calculated using the formula (M1 / M0)×100%.
[0050] The total mass of magnesium ions contained in the bone minerals was determined using an acid digestion method. This method included: weighing a certain mass of bone minerals into a quartz bottle, adding an appropriate amount of concentrated hydrochloric acid or concentrated nitric acid as a solvent to completely dissolve the sample (with ultrasonic assistance), transferring the resulting solution to a 100mL volumetric flask, rinsing the quartz bottle (10mL x 3) with purified water, transferring the rinsing solution to the volumetric flask, adding purified water slightly below the 100mL mark, adjusting the pH to approximately 2.8 with hydrochloric acid (or nitric acid), and then bringing the volume to 100mL. The magnesium ion content (C0, mg / L) in the resulting solution was measured using ICP-OES. Multiplying the measured magnesium content C0 by 100mL yielded the total mass of magnesium ions in the bone minerals, M0 = 0.1C0 (mg).
[0051] In some embodiments, the bone samples described herein include natural bone, artificial bone repair materials, and other bone organoids. In some specific embodiments, the bone samples described herein are selected from natural bone.
[0052] Technical Effects: The method of this invention has a simple experimental operation process, and all tests can be performed using relevant professional analytical testing equipment. The test results are highly accurate and easy to promote. This invention can facilitate the accurate evaluation of bone magnesium status, the chemical evaluation of artificial bone repair materials and bone organoids, and the study of the relationship between readily exchangeable magnesium in bone and related biochemical indicators. It has broad application prospects in bone health diagnosis, the development of artificial bone repair materials and bone organoids, the study of the changing patterns of readily exchangeable magnesium in physiological and pathological states, forensic bone analysis, and the study of bone fossils. Detailed Implementation
[0053] The invention will be further explained below with reference to specific examples.
[0054] Unless otherwise specified, all reagents mentioned in the following examples are of analytical grade or higher, all water is purified water, and all glass containers are made of high borosilicate glass.
[0055] The concentrations of magnesium ions were obtained by inductively coupled plasma optical emission spectrometry (ICP-OES) or inductively coupled plasma mass spectrometry (ICP-MS).
[0056] Example
[0057] Preparation of bone minerals
[0058] A suitable amount of bone sample and water were added to a hydrothermal reactor made of polytetrafluoroethylene (PTFE) and reacted at 190°C for 3 hours. After cooling, the softened bone sample was removed and ground into powder in an agate mortar. The powdered sample was then immersed in 30% hydrogen peroxide at room temperature for 1-2 hours (ultrasonic-assisted), followed by solid-liquid separation by vacuum filtration. The resulting solid sample was further placed in an ethanol-water solution (V / V = ~1 / 1) and stirred at 85°C for 4 hours, followed by solid-liquid separation by vacuum filtration. The resulting solid sample was then further dried using a rotary evaporator under reduced pressure at a temperature of 60-80°C, a vacuum of less than 50 mbar (0.095 kPa), a rotation speed of approximately 100 rpm, and a drying time of 1-2 hours. The resulting dried powder sample is the powdered bone mineral.
[0059] The mass and percentage of magnesium ions contained in bone minerals
[0060] The total mass of magnesium ions in bone minerals was determined by acid digestion. The specific procedure is as follows: 100.00 mg of bone minerals was weighed into a quartz bottle, and concentrated hydrochloric acid or concentrated nitric acid (1-3 mL) was added as a solvent to completely dissolve the sample (with ultrasonic assistance). The resulting solution was then transferred to a 100 mL volumetric flask. The quartz bottle was rinsed with water (10 mL × 3), and the rinsing solution was transferred to the volumetric flask as well. Water was added to slightly below the 100 mL mark. The pH of the solution was adjusted to approximately 2.8 with hydrochloric acid (or nitric acid), and the volume was brought to 100 mL. The magnesium ion concentration C0 (mg / L) in the solution was measured by ICP-OES, and the result was 5.31 ± 0.16 mg / L. Multiplying the measured magnesium ion concentration C0 by 100 mL yielded the total mass of magnesium ions in the bone minerals, M0, which was 0.531 ± 0.016 mg. The percentage of magnesium ions in the bone mineral sample is calculated by dividing the total mass M0 of magnesium ions in the bone minerals by the mass M of the bone minerals [(M0 / M)×100%]. The result is 0.53±0.02%.
[0061] Example 1
[0062] (1) In a 250mL flask, add water (100mL) and bone minerals (1.5000g), then add alendronic acid (75.0mg) to the above solution, seal and stir for 96h at a temperature of 20℃-36℃, with a stirring speed of 60-300rpm.
[0063] (2) After the reaction is complete, the mixture obtained in step (1) is separated into solid and liquid by filtration (or centrifugation). 2M-3M hydrochloric acid (or nitric acid) is added dropwise to the obtained filtrate to adjust the pH value of the solution to about 2.8.
[0064] (3) Transfer the solution obtained in step (2) to a volumetric flask and add water to make up to 100 mL;
[0065] (4) Take a sample from the solution obtained in step (3) and determine the concentration of magnesium ions (C1) in the sample solution by ICP-OES. The concentration is 20.32±0.12 mg / L. Then calculate the mass of magnesium ions in the solution (M1) as 2.03±0.01 mg.
[0066] (5) Divide the M1 (2.03±0.01mg) obtained in step (4) by the total magnesium content M0 (mass of bone minerals to be tested × percentage of magnesium ions (1.5000g × 0.53±0.02%) = 7.95±0.30mg) in the bone minerals in step (1), i.e. (M1 / M0)×100%, and calculate the content of easily exchangeable magnesium ions in the bone minerals as 25.47±0.16%.
[0067] Example 2
[0068] (1) Add water (100 mL) and bone minerals (1.5000 g) to a 250 mL flask, then add alendronic acid (90.0 mg) to the above solution, seal and stir for 96 h at a temperature of 20℃-36℃, with a stirring speed of 60-300 rpm.
[0069] (2) After the reaction is complete, the mixture obtained in step (1) is separated into solid and liquid by filtration (or centrifugation). 2M-3M hydrochloric acid (or nitric acid) is added to the filtrate to adjust the pH of the solution to about 2.8.
[0070] (3) Transfer the solution obtained in step (2) to a volumetric flask and add water to make up to 100 mL;
[0071] (4) Take a sample from the solution obtained in step (3) and determine the concentration of magnesium ions (C1) in the sample solution by ICP-OES. The concentration is 20.11±0.08 mg / L. Then calculate the mass of magnesium ions (M1) in the solution as (2.01±0.01) mg. (5) Divide the M1 (2.01±0.01 mg) obtained in step (4) by the total amount of magnesium in the bone minerals in step (1) M0 (7.95±0.30 mg, calculated in the same way as above), i.e. (M1 / M0)×100%. Calculate the content of easily exchangeable magnesium ions in the bone minerals as 25.28±0.16%.
[0072] Example 3
[0073] (1) Add water (100 mL) and bone minerals (1.5000 g) to a 250 mL flask, then add alendronic acid (100.0 mg) to the above solution, seal and stir for 96 h at a temperature of 20℃-36℃, with a stirring speed of 60-300 rpm.
[0074] (2) After the reaction is complete, the mixture from step (1) is separated into solid and liquid by filtration (or centrifugation). 2M-3M hydrochloric acid (or nitric acid) is added to the filtrate to adjust the pH of the solution to about 2.8.
[0075] (3) Transfer the solution obtained in step (2) to a volumetric flask and add water to make up to 100 mL;
[0076] (4) Take a sample from the solution obtained in step (3) and determine the concentration of magnesium ions (C1) in the sample solution by ICP-OES. The concentration is 20.55±0.06mg / L. Then calculate the mass of magnesium ions (M1) in the solution as 2.05±0.01mg. (5) Divide the M1 (2.05±0.01mg) obtained in step (4) by the total amount of magnesium in the bone minerals in step (1) M0 (7.95±0.30mg, calculated in the same way as above), i.e. (M1 / M0)×100%, and calculate the content of easily exchangeable magnesium ions in the bone minerals as 25.79±0.16%.
[0077] Example 4
[0078] (1) Add water (100 mL) and bone minerals (1.0000 g) to a 250 mL flask, then add alendronic acid (50.0 mg) to the above solution, seal and stir for 96 h at a temperature of 20℃-36℃, with a stirring speed of 60-300 rpm.
[0079] (2) After the reaction is complete, the mixture obtained in step (1) is separated into solid and liquid by filtration (or centrifugation). 2M-3M hydrochloric acid (or nitric acid) is added to the filtrate to adjust the pH of the solution to about 2.8.
[0080] (3) Transfer the solution obtained in step (2) to a volumetric flask and add water to make up to 100 mL;
[0081] (4) Take a sample from the solution obtained in step (3) and determine the concentration of magnesium ions (C1) in the sample solution by ICP-OES. The concentration is 11.09±0.10mg / L. Then calculate the mass of magnesium ions (M1) in the solution as 1.11±0.01mg. (5) Divide the M1 (1.11±0.01mg) obtained in step (4) by the total amount of magnesium in the bone minerals M0 (5.30±0.20mg) in step (1), i.e. (M1 / M0)×100%, and calculate the content of easily exchangeable magnesium ions in the bone minerals as 20.9±0.2%.
[0082] Example 5
[0083] (1) Add water (100 mL) and bone minerals (1.5000 g) to a 250 mL flask, then add alendronic acid (60.0 mg) to the above solution, seal and stir for 96 h at a temperature of 20℃-36℃, with a stirring speed of 60-300 rpm.
[0084] (2) After the reaction is complete, the mixture obtained in step (1) is separated into solid and liquid by filtration (or centrifugation). 2M-3M hydrochloric acid (or nitric acid) is added to the filtrate to adjust the pH of the solution to about 2.8.
[0085] (3) Transfer the solution obtained in step (2) to a volumetric flask and add water to make up to 100 mL;
[0086] (4) Take a sample from the solution obtained in step (3) and determine the concentration of magnesium ions (C1) in the sample solution by ICP-OES. The concentration is 17.83±0.09mg / L. Then calculate the mass of magnesium ions in the solution (M1) as 1.78±0.01mg.
[0087] (5) Divide the M1 (1.78±0.01mg) obtained in step (4) by the total magnesium content M0 (7.95±0.30mg, calculated in the same way as above) in the bone minerals in step (1), i.e. (M1 / M0)×100%, and calculate the content of easily exchangeable magnesium ions in the bone minerals as 22.4±0.2%.
[0088] Example 6
[0089] (1) Add water (100 mL) and bone minerals (1.5000 g) to a 250 mL flask, then add alendronic acid (75.0 mg) to the above solution, seal and stir for 120 h at a temperature of 20℃-36℃, with a stirring speed of 60-300 rpm.
[0090] (2) After the reaction is complete, the mixture obtained in step (1) is separated into solid and liquid by filtration (or centrifugation). 2M-3M hydrochloric acid (or nitric acid) is added to the filtrate to adjust the pH of the solution to about 2.8.
[0091] (3) Transfer the solution obtained in step (2) to a volumetric flask and add water to make up to 100 mL;
[0092] (4) Take a sample from the solution obtained in step (3) and determine the concentration of magnesium ions (C1) in the sample solution by ICP-OES. The concentration is 19.93±0.11mg / L. Then calculate the mass of magnesium ions in the solution (M1) as 1.99±0.01mg.
[0093] (5) Divide the M1 (1.99±0.01mg) obtained in step (4) by the total magnesium content M0 (7.95±0.30mg, calculated in the same way as above) in the bone minerals in step (1), i.e. (M1 / M0)×100, and calculate the content of easily exchangeable magnesium ions in the bone minerals as 25.1±0.2%.
[0094] Example 7
[0095] (1) Add water (100 mL) and bone minerals (1.5000 g) to a 250 mL flask, then add alendronic acid (200.0 mg) to the above solution, seal and stir for 72 h at a temperature of 20℃-36℃, with a stirring speed of 60-300 rpm.
[0096] (2) After the reaction is complete, the mixture obtained in step (1) is separated into solid and liquid by filtration (or centrifugation). 2M-3M hydrochloric acid (or nitric acid) is added to the filtrate to adjust the pH of the solution to about 2.8.
[0097] (3) Transfer the solution obtained in step (2) to a volumetric flask and add water to make up to 100 mL;
[0098] (4) Take a sample from the solution obtained in step (3) and determine the concentration of magnesium ions (C1) in the sample solution by ICP-OES. The concentration is 21.87±0.08mg / L. Then calculate the mass of magnesium ions in the solution (M1) as 2.19±0.01mg.
[0099] (5) Divide the M1 (2.19±0.01mg) obtained in step (4) by the total mass of magnesium ions in the bone minerals M0 (7.95±0.30mg) in step (1), i.e. (M1 / M0)×100, and calculate the content of easily exchangeable magnesium ions in the bone minerals as 27.5±0.2%.
[0100] As can be seen from the above results, the alendronic acid provided by the present invention interacts with an appropriate amount of bone minerals in water, causing all the exchangeable magnesium ions contained in the bone minerals to enter the aqueous solution, thereby realizing the determination of the content of exchangeable magnesium ions in bone minerals and providing an important basis for the accurate assessment of bone magnesium status.
[0101] The preferred embodiments of the present invention have been described in detail above; however, the present invention is not limited thereto. Within the scope of the inventive concept, various simple modifications can be made to the technical solutions of the present invention, including combinations of various technical features in any other suitable manner. These simple modifications and combinations should also be considered as the content disclosed in the present invention and are all within the protection scope of the present invention.
Claims
1. An in vitro method for detecting the content of easily exchangeable magnesium ions in bone minerals, characterized in that, include: An appropriate amount of bone minerals is reacted with alendronic acid in water, and then the concentration of magnesium ions in the aqueous solution is measured. The total mass of magnesium ions in the aqueous solution, M1, is then calculated. The percentage content of easily exchangeable magnesium ions in the bone minerals is calculated using the formula (M1 / M0)×100%, where M0 represents the total mass of magnesium ions contained in the bone minerals.
2. The in vitro detection method according to claim 1, characterized in that, include: An appropriate amount of bone minerals is reacted with alendronic acid in water. After the reaction is complete, the reaction mixture is separated into solid and liquid components. The pH of the resulting filtrate is then adjusted to acidic, and the concentration of magnesium ions in the solution is measured. The total mass M1 of magnesium ions in the aqueous solution is then calculated. The percentage of easily exchangeable magnesium ions in the bone minerals is calculated using the formula (M1 / M0)×100%, where M0 represents the total mass of magnesium ions contained in the bone minerals.
3. The in vitro detection method according to claim 1 or 2, characterized in that, The weight ratio of alendronic acid to the bone mineral is (4.0-15.0):100; preferably, the weight ratio of alendronic acid to the bone mineral is (4.0-10.0):100; more preferably, the weight ratio of alendronic acid to the bone mineral is (5.0-8.0):
100.
4. The in vitro detection method according to claim 1 or 2, characterized in that, The weight ratio of the bone minerals to the water is (1-2):100, and the water is purified water.
5. The in vitro detection method according to claim 1 or 2, characterized in that, The temperature at which the bone minerals react with alendronic acid in water is 20°C to 60°C; preferably 20°C to 50°C; more preferably 20°C to 40°C; and most preferably 20°C to 36°C.
6. The in vitro detection method according to claim 1 or 2, characterized in that, The reaction time of the bone minerals and alendronic acid in water is 48-200 h; preferably 72-150 h; more preferably 96-120 h.
7. The in vitro detection method according to claim 1 or 2, characterized in that, The reaction of the bone minerals with alendronic acid in water is carried out under stirring conditions, with a stirring rate of 60-300 rpm.
8. The in vitro detection method according to claim 1 or 2, characterized in that, The total mass M1 of magnesium ions in the solution is obtained by measuring and calculating the concentration of magnesium ions in the solution, which is determined by inductively coupled plasma atomic emission spectrometry or inductively coupled plasma mass spectrometry.
9. The in vitro detection method according to claim 2, characterized in that, The pH of the resulting filtrate is adjusted to 1.0-5.0; preferably, the pH of the resulting filtrate is adjusted to 2.0-4.0; more preferably, the pH of the resulting filtrate is adjusted to 2.5-3.5; even more preferably, the pH of the resulting filtrate is adjusted to 2.5-3.
0.
10. The in vitro detection method according to claim 1 or 2, characterized in that, It also includes the preparation of the bone minerals: Take an appropriate amount of bone sample and heat it with water to react. After cooling, take out the bone sample and grind it into powder. Soak the powdered sample in hydrogen peroxide and then separate the solid and liquid. Put the obtained solid sample into an ethanol-water solution, heat and stir, then separate the solid and liquid. Dry the obtained solid sample to obtain the bone mineral.
11. The in vitro detection method according to claim 1 or 2, characterized in that, The total mass of magnesium ions contained in the bone minerals was determined by acid digestion of the bone minerals. Weigh a certain mass of bone minerals, add an appropriate amount of concentrated hydrochloric acid or concentrated nitric acid as a solvent, sonicate to completely dissolve the bone minerals, adjust the pH of the resulting solution to 2.0-3.5, and dilute to volume with water; determine the magnesium ion concentration in the resulting solution, and calculate the total mass of magnesium ions contained in the bone minerals.
12. The in vitro detection method according to claim 1 or 2, characterized in that, The bone samples include natural bone, artificial bone repair materials, and other bone organs.
13. Use of alendronate for the in vitro determination of the content of exchangeable magnesium ions in bone minerals.
14. The use according to claim 13, characterized in that, A suitable amount of powdered bone minerals is reacted with alendronic acid in water, and then the concentration of magnesium ions in the aqueous solution is measured. The total mass of magnesium ions in the aqueous solution, M1, is then calculated. The percentage content of easily exchangeable magnesium ions in the bone minerals is calculated using the formula (M1 / M0)×100%, where M0 represents the total mass of magnesium ions contained in the bone minerals.
15. The use according to claim 14, characterized in that, It also includes the preparation of the bone minerals: Take an appropriate amount of bone sample and heat it with water to react. After cooling, take out the bone sample and grind it into powder. Soak the powdered sample in hydrogen peroxide and then separate the solid and liquid. Put the obtained solid sample into an ethanol-water solution, heat and stir, then separate the solid and liquid. Dry the obtained solid sample to obtain bone minerals.
16. The use according to claim 14 or 15, characterized in that, The total mass of magnesium ions contained in the bone minerals was determined using an acid digestion method for bone minerals, including: Weigh a certain mass of bone minerals, add an appropriate amount of concentrated hydrochloric acid or concentrated nitric acid as a solvent, sonicate to completely dissolve the bone minerals, adjust the pH of the resulting solution to 2.0-3.5, and dilute to volume with water; determine the magnesium ion concentration in the resulting solution, and calculate the total mass of magnesium ions contained in the bone minerals.
17. The use according to claim 16, characterized in that, The bone samples include natural bone, artificial bone repair materials, and other bone organs.
